Evaluation of antioxidant co-therapy for polymyxin B-associated nephrotoxicity and mortality: a real-World retrospective cohort study.

J Pharm Policy Pract · 2025 · PMC12710275 · PMID 41415037

Europe PMC DOI

hedged sentence

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

did not reach statistical significanceP = 0.081so close (0.05 < p ≤ 0.1)

Discharge mortality was also lower in the antioxidant group (6.5% vs 13.9%), although this difference did not reach statistical significance ( P = 0.081).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.